Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. - Wikidata - awgldk - TriplyDB

Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease.

Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease.

http://www.wikidata.org/entity/Q35850718

about

Extracellular Vesicles and a Novel Form of Communication in the Brain Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease Nanoscale Extracellular Vesicle Analysis in Alzheimer's Disease Diagnosis and Therapy NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.Digital Detection of Exosomes by Interferometric Imaging Extracellular Vesicle-Associated Aβ Mediates Trans-Neuronal Bioenergetic and Ca2+-Handling Deficits in Alzheimer's Disease Models.Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes.Translating RNA sequencing into clinical diagnostics: opportunities and challenges.Low neural exosomal levels of cellular survival factors in Alzheimer's disease.Metabolic profiling distinguishes three subtypes of Alzheimer's disease.Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy.Human plasma platelet-derived exosomes: effects of aspirin.Novel window on early human neurodevelopment via fetal exosomes in maternal blood.Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging.Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile Genetic effect of interleukin-1 beta (C-511T) polymorphism on the structural covariance network and white matter integrity in Alzheimer's disease.Plasma Exosomes Spread and Cluster Around β-Amyloid Plaques in an Animal Model of Alzheimer's Disease.Secondary Release of Exosomes From Astrocytes Contributes to the Increase in Neural Plasticity and Improvement of Functional Recovery After Stroke in Rats Treated With Exosomes Harvested From MicroRNA 133b-Overexpressing Multipotent Mesenchymal Stro Proteostasis and aging.Physiological and pathological roles of exosomes in the nervous system.MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.Autophagy and the endo/exosomal pathways in health and disease.Exosomes in Parkinson's Disease.Endo-lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms.Exosomes and the Prion Protein: More than One Truth.Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.A novel cell-cell communication mechanism in the nervous system: exosomes.Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV.Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes.Three-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic mice Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress.Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease.Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease.Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype.MicroRNAs in Post-traumatic Stress Disorder.

P2860

Q26750015-ED206B40-1758-46CB-8B12-E36BBA85E5E8 Q26767264-58F4EB2E-8A91-4D63-BACC-5FB6BA1E38E5 Q28072312-0D70FFDB-9E50-49B7-AA48-BA558CE3C6EB Q30352890-F0105F6E-460B-41E1-A2B8-026381686DB4 Q30828939-C07AA522-4565-475A-B657-248AC7C13164 Q30830788-94B1E365-C3CD-4D89-A153-B59C7387B273 Q33628048-8890F982-091D-4B12-91BD-B27C968846CB Q33711915-6FBDBA51-2DBF-4EE0-9E9D-85A308300F2F Q34519034-15634829-EEDD-42C1-A084-9087934155F7 Q35935111-C8113CBC-4710-45A9-B768-F1D8FBCE01C8 Q36100673-E0020246-3579-4499-BDCE-7E380B47C9D1 Q36803316-0A67E0BE-7C65-4E6B-AD1A-31ED1583266B Q36812072-9E7F17BC-7B66-4D11-8DBD-73D04469AF98 Q36891731-682F6BD5-D180-4A1A-8D4C-6BEFC5C2DCA0 Q36891744-D1F53AFF-05DC-4B11-A17F-64BB104F6EA3 Q37049024-46BDECF2-4807-4309-ABF5-175F61DBC7AA Q37591588-27503054-90C3-41F4-B5C5-D91B3DC1F234 Q37617386-BEA87059-84DA-4DA4-BD14-26945BDB585D Q37636981-9F708D3F-E374-4C75-B18D-5B86DB544737 Q38662553-2FAA02E4-CF82-4AB1-A964-1B9E74EB654F Q38712290-0D472638-15A0-484D-A8C0-EFBD4732D87F Q38749271-3A2497D7-5F21-47CD-98F8-7FA9CFDF42E4 Q38802634-DE72680A-3B2B-4962-9453-27BAE2516B75 Q38808517-9FE063F4-0515-422D-8C05-0502E0195DE3 Q38962786-3A0350D6-F801-4E48-A3FC-B59FDD8055FD Q39038974-12D980FF-E4C6-42C1-BB7A-1969AF3F490D Q39057306-891F7C5C-70D0-41DA-A404-F7A3F3050738 Q39058736-F0736837-34FC-49D6-A296-D503C675AEC6 Q39132336-ED38FB1B-8909-4DBD-860A-7915DB50C265 Q39281941-A112B50F-AEC2-4003-918A-8B5A1A01796D Q39320214-C1E8F0E6-0198-4FAA-B317-06B1D9CE85F0 Q39441605-FA501912-EC0F-4BD5-B5E1-AAAB141398B3 Q40141673-D8F5609B-C123-4DBA-9BF6-D53589E1648E Q41575678-5D4E4184-3211-4292-84DE-3778FC5FE462 Q41876717-18DAD21B-F114-452E-A3CC-2A2E597AFDF8 Q42361526-5051F6A9-8B06-4A23-B55E-F12FD4A560D5 Q42705476-DB460CF8-C651-4AB3-8BB8-B45CA6F8BF60 Q44909742-0F108157-150A-437B-8A79-FB1AEF473C62 Q45990397-DCDE623C-7667-4589-BBB2-D3419641467A Q46055081-D8289BB7-7AFC-468A-AC0B-84DF1D444BD1

P2860

Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease.

http://www.wikidata.org/entity/Q35850718

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Altered lysosomal proteins in ...... preclinical Alzheimer disease.

@ast

Altered lysosomal proteins in ...... preclinical Alzheimer disease.

@en

type

label

Altered lysosomal proteins in ...... preclinical Alzheimer disease.

@ast

Altered lysosomal proteins in ...... preclinical Alzheimer disease.

@en

prefLabel

Altered lysosomal proteins in ...... preclinical Alzheimer disease.

@ast

Altered lysosomal proteins in ...... preclinical Alzheimer disease.

@en

P1433

Q35850718-5C34E533-27F5-468A-B39A-B5F5F841899E

P1476

Q35850718-29B99BC4-829B-4B50-8CEC-835923371068

P2093

Q35850718-0401D6AA-A3FD-4061-B30D-204DCFB0B9B2

Q35850718-29CB6452-A6E2-4CEA-B846-91EF2D52D64F

Q35850718-2DC33716-1FBE-4CAF-9E6A-6E011E1C4D07

Q35850718-7344C54E-A876-409D-87A0-A7A38DD45EA5

P2860

Q35850718-2FAF0FE6-FF86-414B-A0B7-4EEE6E0214BA

Q35850718-39C2F91D-CB8C-4EAE-9AB5-54C675ED4AE1

Q35850718-3C1FCC2D-783A-427F-974F-9EB943FB5338

Q35850718-46063C8C-A7A7-4A8D-83DE-D62FE710235F

Q35850718-49B0D441-9192-4C18-A2FE-6A3FD14FD6BC

Q35850718-504A437A-929F-4667-8345-56E4CCA36856

Q35850718-511600DD-8774-4031-941C-78E547F60410

Q35850718-59020E6D-574E-40D8-80DB-84B413F570BD

Q35850718-68560D50-B2B6-4E2C-9DAE-88954F6836D3

Q35850718-69CB4063-93E7-4B8C-A5BC-9C7348278EE5

P304

Q35850718-E073CAE9-3971-4E70-93DF-74E0AAB10FA7

P31

Q35850718-34C9F924-0CD0-4409-89F1-2B6E75B3CD7C

P356

Q35850718-A169CDED-0064-4674-BD9D-57C6F9C45898

P407

Q35850718-F3654127-3ED4-40AC-A68D-C16CFC703669

P433

Q35850718-447FA023-BB18-4287-BD58-766B33BE7471

P478

Q35850718-2B300A23-D035-4673-AE48-5983506A313B

P50

Q35850718-12152CAC-7256-4C54-9F31-09EC5FFEF7E2

Q35850718-7EE86FCB-E516-47E4-8A9E-33CA75CBD89E

Q35850718-EA8D56EE-632D-4251-9E53-9228EB84994A

P577

Q35850718-80B6897D-1214-4ECC-987C-C19C0246C851

P698

Q35850718-13A67BFE-9951-46AA-A6E7-BB0483BAF2B7

P921

Q35850718-E5299031-A431-4A74-9820-29CDA06F3FC4

P932

Q35850718-8A095843-81FA-4A50-B345-7ECBD48A1965

P356

WNL.0000000000001702

P1433

P1476

Altered lysosomal proteins in ...... preclinical Alzheimer disease.

@en

P2093

Dimitrios Kapogiannis

http://www.w3.org/2001/XMLSchema#string

Edward J Goetzl

http://www.w3.org/2001/XMLSchema#string

Erin L Abner

http://www.w3.org/2001/XMLSchema#string

Janice B Schwartz

http://www.w3.org/2001/XMLSchema#string

P2860

The lysosomal polypeptide transporter TAPL is stabilized by interaction with LAMP-1 and LAMP-2

Classification of primary progressive aphasia and its variants

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

Cloning and sequence analysis of cDNA for human cathepsin D

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Molecular dissection of autophagy: two ubiquitin-like systems

Cathepsin D--many functions of one aspartic protease

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Mild cognitive impairment as a diagnostic entity

P304

40-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000001702

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Bruce L. Miller

Ronald C. Petersen

P577

2015-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26062630

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4501943

http://www.w3.org/2001/XMLSchema#string